{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:05:13Z","timestamp":1787627113135,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer's Research UK","doi-asserted-by":"publisher","award":["ARUK-EG2016A-6; ARUK-PhD2023-002"],"award-info":[{"award-number":["ARUK-EG2016A-6; ARUK-PhD2023-002"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer's Research UK","doi-asserted-by":"publisher","award":["ARUK-PhD2023-002"],"award-info":[{"award-number":["ARUK-PhD2023-002"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["225442\/Z\/22\/Z"],"award-info":[{"award-number":["225442\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012290","name":"Dyson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the neurodegenerative disease progressive supranuclear palsy (PSP), tau pathology progresses through the brain in a stereotypical spatiotemporal pattern, and where tau pathology appears, synapses are lost. We tested the hypothesis that pathological tau contributes to synapse loss and may spread through the brain by moving from presynapses to postsynapses. Using postmortem PSP brain samples and a living human brain slice culture model, we observe pathological tau in synaptic pairs and evidence that oligomeric tau can enter live human postsynapses. Proteomics revealed increased clusterin in synapses in PSP, and super-resolution imaging showed clusterin colocalized with tau in synapses in close enough proximity to be binding partners, which may mediate tau spread. Accumulation of tau in synapses correlated with synapse loss, and synaptic engulfment by astrocytes was observed, suggesting that astrocytes contribute to synapse loss. Together, these data indicate that targeting synaptic tau is a promising approach to treat PSP.<\/jats:p>","DOI":"10.1038\/s41593-025-01992-5","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T09:02:14Z","timestamp":1752656534000},"page":"1622-1634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1647-8642","authenticated-orcid":false,"given":"Robert I.","family":"McGeachan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Keavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Simzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-403X","authenticated-orcid":false,"given":"Ya Yin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell P.","family":"Spires-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3903-6361","authenticated-orcid":false,"given":"Kristjan","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-5626","authenticated-orcid":false,"given":"Soraya","family":"Meftah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ravingerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Scutariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis W.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-5943","authenticated-orcid":false,"given":"Makis","family":"Tzioras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6975-5430","authenticated-orcid":false,"given":"Jane","family":"Tulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1980-9873","authenticated-orcid":false,"given":"Sam A.","family":"Booker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Liaquat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hindley-Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Geary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-830X","authenticated-orcid":false,"given":"Paul M.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7552-7358","authenticated-orcid":false,"given":"Claire S.","family":"Durrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2530-0598","authenticated-orcid":false,"given":"Tara L.","family":"Spires-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"1992_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","volume":"10","author":"JC Steele","year":"1964","unstructured":"Steele, J. C., Richardson, J. C. & Olszewski, J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol. 10, 333\u2013359 (1964).","journal-title":"Arch. Neurol."},{"key":"1992_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs, G. G. et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 140, 99\u2013119 (2020).","journal-title":"Acta Neuropathol."},{"key":"1992_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/jnen\/60.5.403","volume":"60","author":"EH Bigio","year":"2001","unstructured":"Bigio, E. H. et al. Cortical synapse loss in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 60, 403\u2013410 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1992_CR4","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/mds.28188","volume":"35","author":"N Holland","year":"2020","unstructured":"Holland, N. et al. Synaptic loss in primary tauopathies revealed by [11C]UCB-J positron emission tomography. Mov. Disord. 35, 1834\u20131842 (2020).","journal-title":"Mov. Disord."},{"key":"1992_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent, S. A., Spires-Jones, T. L. & Durrant, C. S. The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol. 140, 417\u2013447 (2020).","journal-title":"Acta Neuropathol."},{"key":"1992_CR6","doi-asserted-by":"publisher","first-page":"e80834","DOI":"10.1371\/journal.pone.0080834","volume":"8","author":"KJ Kopeikina","year":"2013","unstructured":"Kopeikina, K. J. et al. Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy. PLoS ONE 8, e80834 (2013).","journal-title":"PLoS ONE"},{"key":"1992_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.neuron.2018.01.022","volume":"97","author":"J McInnes","year":"2018","unstructured":"McInnes, J. et al. Synaptogyrin-3 mediates presynaptic dysfunction induced by tau. Neuron 97, 823\u2013835 (2018).","journal-title":"Neuron"},{"key":"1992_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15295","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou, L. et al. Tau association with synaptic vesicles causes presynaptic dysfunction. Nat. Commun. 8, 15295 (2017).","journal-title":"Nat. Commun."},{"key":"1992_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh1448","volume":"7","author":"G Meisl","year":"2021","unstructured":"Meisl, G. et al. In vivo rate-determining steps of tau seed accumulation in Alzheimer\u2019s disease. Sci. Adv. 7, eabh1448 (2021).","journal-title":"Sci. Adv."},{"key":"1992_CR10","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","volume":"111","author":"M Colom-Cadena","year":"2023","unstructured":"Colom-Cadena, M. et al. Synaptic oligomeric tau in Alzheimer\u2019s disease\u2014a potential culprit in the spread of tau pathology through the brain. Neuron 111, 2170\u20132183 (2023).","journal-title":"Neuron"},{"key":"1992_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A de Calignon","year":"2012","unstructured":"de Calignon, A. et al. Propagation of tau pathology in a model of early Alzheimer\u2019s disease. Neuron 73, 685\u2013697 (2012).","journal-title":"Neuron"},{"key":"1992_CR12","doi-asserted-by":"publisher","first-page":"e45881","DOI":"10.1371\/journal.pone.0045881","volume":"7","author":"JA Harris","year":"2012","unstructured":"Harris, J. A. et al. Human P301L-mutant tau expression in mouse entorhinal\u2013hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits. PLoS ONE 7, e45881 (2012).","journal-title":"PLoS ONE"},{"key":"1992_CR13","doi-asserted-by":"publisher","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7, e31302 (2012).","journal-title":"PLoS ONE"},{"key":"1992_CR14","doi-asserted-by":"publisher","first-page":"e21965","DOI":"10.1002\/syn.21965","volume":"71","author":"EK Pickett","year":"2017","unstructured":"Pickett, E. K. et al. Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer\u2019s disease. Synapse 71, e21965 (2017).","journal-title":"Synapse"},{"key":"1992_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw6404","volume":"5","author":"S Wegmann","year":"2019","unstructured":"Wegmann, S. et al. Experimental evidence for the age dependence of tau protein spread in the brain. Sci. Adv. 5, eaaw6404 (2019).","journal-title":"Sci. Adv."},{"key":"1992_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/23982128231191046","volume":"7","author":"C Davies","year":"2023","unstructured":"Davies, C. et al. Apolipoprotein E isoform does not influence trans-synaptic spread of tau pathology in a mouse model. Brain Neurosci. Adv. 7, 23982128231191046 (2023).","journal-title":"Brain Neurosci. Adv."},{"key":"1992_CR17","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera, F. et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc. Natl Acad. Sci. USA 110, 9535\u20139540 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1992_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28896-3","volume":"13","author":"N Franzmeier","year":"2022","unstructured":"Franzmeier, N. et al. Tau deposition patterns are associated with functional connectivity in primary tauopathies. Nat. Commun. 13, 1362 (2022).","journal-title":"Nat. Commun."},{"key":"1992_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.expneurol.2009.07.029","volume":"223","author":"AB Rocher","year":"2010","unstructured":"Rocher, A. B. et al. Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs. Exp. Neurol. 223, 385\u2013393 (2010).","journal-title":"Exp. Neurol."},{"key":"1992_CR20","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/nature08890","volume":"464","author":"A de Calignon","year":"2010","unstructured":"de Calignon, A. et al. Caspase activation precedes and leads to tangles. Nature 464, 1201\u20131204 (2010).","journal-title":"Nature"},{"key":"1992_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2478\/s13380-012-0032-y","volume":"3","author":"KJ Kopeikina","year":"2012","unstructured":"Kopeikina, K. J., Hyman, B. T. & Spires-Jones, T. L. Soluble forms of tau are toxic in Alzheimer\u2019s disease. Transl. Neurosci. 3, 223\u2013233 (2012).","journal-title":"Transl. Neurosci."},{"key":"1992_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-39","volume":"6","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves, C. A. et al. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol. Neurodegener. 6, 39 (2011).","journal-title":"Mol. Neurodegener."},{"key":"1992_CR23","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1016\/j.celrep.2019.11.044","volume":"29","author":"EK Pickett","year":"2019","unstructured":"Pickett, E. K. et al. Amyloid \u03b2 and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer\u2019s disease. Cell Rep. 29, 3592\u20133604 (2019).","journal-title":"Cell Rep."},{"key":"1992_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.neuron.2020.12.016","volume":"109","author":"P Largo-Barrientos","year":"2021","unstructured":"Largo-Barrientos, P. et al. Lowering synaptogyrin-3 expression rescues tau-induced memory defects and synaptic loss in the presence of microglial activation. Neuron 109, 767\u2013777 (2021).","journal-title":"Neuron"},{"key":"1992_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer, D. P. et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691\u2013705 (2012).","journal-title":"Neuron"},{"key":"1992_CR26","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41586-020-03060-3","volume":"590","author":"JH Lee","year":"2021","unstructured":"Lee, J. H. et al. Astrocytes phagocytose adult hippocampal synapses for circuit homeostasis. Nature 590, 612\u2013617 (2021).","journal-title":"Nature"},{"key":"1992_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101175","volume":"19","author":"M Tzioras","year":"2023","unstructured":"Tzioras, M. et al. Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer\u2019s disease via MFG-E8. Cell Rep. Med. 19, 101175 (2023).","journal-title":"Cell Rep. Med."},{"key":"1992_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-023-02667-w","volume":"147","author":"LW Taylor","year":"2024","unstructured":"Taylor, L. W. et al. p-tau Ser356 is associated with Alzheimer\u2019s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003. Acta Neuropathol. 147, 7 (2024).","journal-title":"Acta Neuropathol."},{"key":"1992_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jamaneurol.2023.3530","volume":"80","author":"RN Taddei","year":"2023","unstructured":"Taddei, R. N. et al. Tau oligomer-containing synapse elimination by microglia and astrocytes in Alzheimer disease. JAMA Neurol. 80, 1209\u20131221 (2023).","journal-title":"JAMA Neurol."},{"key":"1992_CR30","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1096\/fj.11-199851","volume":"26","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves, C. A. et al. Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease. FASEB J. 26, 1946\u20131959 (2012).","journal-title":"FASEB J."},{"key":"1992_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03566-5","volume":"9","author":"L Weinhard","year":"2018","unstructured":"Weinhard, L. et al. Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction. Nat. Commun. 9, 1228 (2018).","journal-title":"Nat. Commun."},{"key":"1992_CR32","doi-asserted-by":"publisher","unstructured":"Gene Ontology Consortium et al. The Gene Ontology knowledgebase in 2023. Genetics https:\/\/doi.org\/10.1093\/genetics\/iyad031 (2023).","DOI":"10.1093\/genetics\/iyad031"},{"key":"1992_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcz003","volume":"1","author":"RJ Jackson","year":"2019","unstructured":"Jackson, R. J. et al. Clusterin accumulates in synapses in Alzheimer\u2019s disease and is increased in apolipoprotein E4 carriers. Brain Commun. 1, fcz003 (2019).","journal-title":"Brain Commun."},{"key":"1992_CR34","doi-asserted-by":"publisher","unstructured":"McGeachan, R. I. et al. Divergent actions of physiological and pathological amyloid-\u03b2 on synapses in live human brain slice cultures. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-025-58879-z (2025).","DOI":"10.1038\/s41467-025-58879-z"},{"key":"1992_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L., Han, Y. & He, Q. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"1992_CR36","doi-asserted-by":"publisher","unstructured":"S\u00e1rk\u00e1ny, B. et al. Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-024-02749-3 (2024).","DOI":"10.1007\/s00401-024-02749-3"},{"key":"1992_CR37","doi-asserted-by":"publisher","unstructured":"Tai, H. C. et al. The tau oligomer antibody APNmAb005 detects early-stage pathological tau enriched at synapses and rescues neuronal loss in long-term treatments. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.06.24.497452 (2022).","DOI":"10.1101\/2022.06.24.497452"},{"key":"1992_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.neuron.2016.12.023","volume":"93","author":"H Fu","year":"2017","unstructured":"Fu, H. et al. Tau pathology induces excitatory neuron loss, grid cell dysfunction and spatial memory deficits reminiscent of early Alzheimer\u2019s disease. Neuron 93, 533\u2013541 (2017).","journal-title":"Neuron"},{"key":"1992_CR39","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/ene.15043","volume":"29","author":"H Kurucu","year":"2022","unstructured":"Kurucu, H. et al. Inhibitory synapse loss and accumulation of amyloid \u03b2 in inhibitory presynaptic terminals in Alzheimer\u2019s disease. Eur. J. Neurol. 29, 1311\u20131323 (2022).","journal-title":"Eur. J. Neurol."},{"key":"1992_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/nan.13006","volume":"50","author":"O Dando","year":"2024","unstructured":"Dando, O. et al. Synaptic gene expression changes in frontotemporal dementia due to the MAPT 10 +16 mutation. Neuropathol. Appl Neurobiol. 50, e13006 (2024).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"1992_CR41","doi-asserted-by":"publisher","first-page":"1514.e1","DOI":"10.1016\/j.neurobiolaging.2014.01.010","volume":"35","author":"R Ferrari","year":"2014","unstructured":"Ferrari, R. et al. Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy. Neurobiol. Aging 35, 1514.e1\u20131514.e12 (2014).","journal-title":"Neurobiol. Aging"},{"key":"1992_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52025-x","volume":"15","author":"K Farrell","year":"2024","unstructured":"Farrell, K. et al. Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes. Nat. Commun. 15, 7880 (2024).","journal-title":"Nat. Commun."},{"key":"1992_CR43","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41593-022-01191-6","volume":"25","author":"P Martinez","year":"2022","unstructured":"Martinez, P. et al. Bassoon contributes to tau-seed propagation and neurotoxicity. Nat. Neurosci. 25, 1597\u20131607 (2022).","journal-title":"Nat. Neurosci."},{"key":"1992_CR44","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/brain\/awad309","volume":"147","author":"IJ Hartnell","year":"2024","unstructured":"Hartnell, I. J. et al. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Brain 147, 590\u2013606 (2024).","journal-title":"Brain"},{"key":"1992_CR45","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712\u2013716 (2016).","journal-title":"Science"},{"key":"1992_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202100287","volume":"44","author":"P Yuste-Checa","year":"2022","unstructured":"Yuste-Checa, P., Bracher, A. & Hartl, F. U. The chaperone clusterin in neurodegeneration\u2014friend or foe? Bioessays 44, 2100287 (2022).","journal-title":"Bioessays"},{"key":"1992_CR47","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awaa223","volume":"143","author":"E Drummond","year":"2020","unstructured":"Drummond, E. et al. Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain. Brain 143, 2803\u20132817 (2020).","journal-title":"Brain"},{"key":"1992_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01079-1","volume":"8","author":"AM Wojtas","year":"2020","unstructured":"Wojtas, A. M. et al. Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation. Acta Neuropathol. Commun. 8, 210 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"1992_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25060-1","volume":"12","author":"P Yuste-Checa","year":"2021","unstructured":"Yuste-Checa, P. et al. The extracellular chaperone clusterin enhances tau aggregate seeding in a cellular model. Nat. Commun. 12, 4863 (2021).","journal-title":"Nat. Commun."},{"key":"1992_CR50","doi-asserted-by":"publisher","unstructured":"Sharma, A. et al. Single-cell atlas of progressive supranuclear palsy reveals a distinct hybrid glial cell population. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.04.11.439393 (2021).","DOI":"10.1101\/2021.04.11.439393"},{"key":"1992_CR51","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.3758\/s13428-021-01546-0","volume":"53","author":"L Kumle","year":"2021","unstructured":"Kumle, L., V\u00f5, M. L. H. & Draschkow, D. Estimating power in (generalized) linear mixed models: an open introduction and tutorial in R. Behav. Res Methods 53, 2528\u20132543 (2021).","journal-title":"Behav. Res Methods"},{"key":"1992_CR52","doi-asserted-by":"publisher","unstructured":"Kay, K. R. et al. Studying synapses in human brain with array tomography and electron microscopy. Nat. Protoc. https:\/\/doi.org\/10.1038\/nprot.2013.078 (2013).","DOI":"10.1038\/nprot.2013.078"},{"key":"1992_CR53","unstructured":"Spires-Jones, T. Array tomography movie. DataShare https:\/\/datashare.ed.ac.uk\/handle\/10283\/850 (2015)."},{"key":"1992_CR54","unstructured":"Spires-Jones, T. Array tomography image analysis macros 2024. DataShare https:\/\/datashare.ed.ac.uk\/handle\/10283\/8940 (2025)."},{"key":"1992_CR55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-4939-9686-5_12","volume":"2040","author":"T Zimmermann","year":"2019","unstructured":"Zimmermann, T. Photobleaching and sensitized emission-based methods for the detection of F\u00f6rster resonance energy transfer. Methods Mol. Biol. 2040, 235\u2013274 (2019).","journal-title":"Methods Mol. Biol."},{"key":"1992_CR56","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/brain\/awac396","volume":"146","author":"F McLeod","year":"2023","unstructured":"McLeod, F. et al. Altered synaptic connectivity in an in vitro human model of STXBP1 encephalopathy. Brain 146, 850\u2013857 (2023).","journal-title":"Brain"},{"key":"1992_CR57","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s40478-019-0847-7","volume":"7","author":"R Hesse","year":"2019","unstructured":"Hesse, R. et al. Comparative profiling of the synaptic proteome from Alzheimer\u2019s disease patients with focus on the APOE genotype. Acta Neuropathol. Commun. 7, 214 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"1992_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"1992_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neuron.2019.05.002","volume":"103","author":"F Koopmans","year":"2019","unstructured":"Koopmans, F. et al. SynGO: an evidence-based, expert-curated knowledge base for the synapse. Neuron 103, 217\u2013234.e4 (2019).","journal-title":"Neuron"},{"key":"1992_CR60","unstructured":"McGeachan, R. et al. Data from paper: evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy. DataShare https:\/\/datashare.ed.ac.uk\/handle\/10283\/8977 (2025)."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-01992-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-01992-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-01992-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:31:38Z","timestamp":1757223098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-01992-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1992"],"URL":"https:\/\/doi.org\/10.1038\/s41593-025-01992-5","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.L.S.-J. is a scientific advisory board member of Scottish Brain Sciences, Cognition Therapeutics and Race Against Dementia, and has received consulting fees or honoraria from Jay Therapeutics, Sanofi, AbbVie, Merck and Eisai. M.T. is an employee of Scottish Brain Sciences. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}